FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marcos De Lima

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Ulas D Bayraktar; Farid Boulad; Hugo R Castro-Malaspina; Richard E Champlin; Julianne Chen; Alexander Chiattone; Marcos De Lima; Sergio Giralt; Ann A Jakubowski; Nancy A Kernan; Molly Maloy; Richard J O'Reilly; Gabriela Rondon; Rima M Saliba; Borje S Andersson; Esperanza B Papadopoulos
Ex Vivo T Cell-Depleted versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission.
Partow Kebriaei; Susan O'Brien; Farhad Ravandi; Deborah Thomas; Kaci Wilhelm; Laura Worth; Mark Brandt; Richard E Champlin; Stefan Ciurea; Marcos De Lima; Hagop Kantarjian
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicin.
L M Poon; U R Popat; Muzaffar H Qazilbash; Gabriela Rondon; Elizabeth J Shpall; Laura L Worth; Yago Nieto; R Bassett; Richard E Champlin; L Cooper; Marcos De Lima; A Hamdi; Chitra Hosing; Roy B Jones; Partow Kebriaei
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marcos De Lima (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ulas D Bayraktar; Farid Boulad; Hugo R Castro-Malaspina; Richard E Champlin; Julianne Chen; Alexander Chiattone; Marcos De Lima; Sergio Giralt; Ann A Jakubowski; Nancy A Kernan; Molly Maloy; Richard J O'Reilly; Gabriela Rondon; Rima M Saliba; Borje S Andersson; Esperanza B Papadopoulos
Ex Vivo T Cell-Depleted versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(6):898-903.
2013: Partow Kebriaei; Susan O'Brien; Farhad Ravandi; Deborah Thomas; Kaci Wilhelm; Laura Worth; Mark Brandt; Richard E Champlin; Stefan Ciurea; Marcos De Lima; Hagop Kantarjian
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicin.
Clinical lymphoma, myeloma & leukemia 2013;13(3):296-301.
2013: L M Poon; U R Popat; Muzaffar H Qazilbash; Gabriela Rondon; Elizabeth J Shpall; Laura L Worth; Yago Nieto; R Bassett; Richard E Champlin; L Cooper; Marcos De Lima; A Hamdi; Chitra Hosing; Roy B Jones; Partow Kebriaei
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia.
Bone marrow transplantation 2013;48(5):666-70.
2013: Y Chen; Jorge Cortes; N Daver; Marcos De Lima; Zeev Estrov; Stefan Faderl; Guillermo Garcia-Manero; Elias Jabbour; T Kadia; Andrew Lamb; Partow Kebriaei; Susan O'Brien; Sherry Pierce; W Qiao; Lynne V Abruzzo; Farhad Ravandi
Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation.
Leukemia 2013;27(4):836-42.
2013: Elias Jabbour; Tapan Kadia; Hagop Kantarjian; Issa Khouri; Ebru Koca; Michael S Mathisen; Betul Oran; Simrit Parmar; Sherry Pierce; Uday Popat; Gabriela Rondon; Maria Tanaka; Richard Champlin; Julianne Chen; Naval Daver; Guillermo Garcia-Manero; Sergio Giralt; Marcos De Lima
Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study.
American journal of hematology 2013;88(3):198-200.
2013: Simrit Parmar; Gabriela Rondon; Peter Thall; Partow Kebriaei; Issa Khouri; Paolo Anderlini; Ronald Bassett; Richard Champlin; Marcos De Lima; Prasanth Ganesan; Sergio Giralt
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(3):474-80.
2013: Betul Oran; Uday Popat; Muzaffar H Qazilbash; Farhad Ravandi; Gabriela Rondon; Lynn Abruzzo; Borje S Andersson; Qaiser Bashir; Richard Champlin; Julianne Chen; Guillermo Garcia-Manero; Partow Kebriaei; Issa F Khouri; Ebru Koca; Marcos De Lima
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):214-20.
2013: Partow Kebriaei; C Ledesma; T Madden; Yago Nieto; Uday Popat; Muzaffar H Qazilbash; Elizabeth J Shpall; P F Thall; X Wang; Richard E Champlin; Marcos De Lima; Chitra Hosing; Roy B Jones; Amin Alousi; Borje S Andersson
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
Bone marrow transplantation 2013;48(1):26-31.
2012: Stefan O Ciurea; Marcos De Lima; Marcelo Fernandez-Vina; Chitra Hosing; Ying Jiang; Partow Kebriaei; Issa Khouri; Marina Konopleva; Martin Korbling; Nivia Montes; Victor Mulanovich; Yago Nieto; Simrit Parmar; Uday Popat; Muzaffar H Qazilbash; Gabriela Rondon; Rima M Saliba; Elizabeth Shpall; Sa A Wang; Gheath Alatrash; Amin Alousi; Qaiser Bashir; Roland Bassett; Ulas D Bayraktar; Doyle Bosque; Julianne Chen; Richard E Champlin
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(12):1835-44.
2012: Partow Kebriaei; Issa Khouri; C Ledesma; Yago Nieto; Simrit Parmar; Uday Popat; Muzaffar H Qazilbash; Elizabeth J Shpall; Roland Basset; Richard E Champlin; S Ciurea; Marcos De Lima; Chitra Hosing; Roy B Jones; Amin Alousi; Borje S Andersson
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(12):1819-26.
2012: Stefan O Ciurea; Daniel Couriel; Roland Bassett; Richard E Champlin; Ka Wah Chan; Marcelo Fernandez-Vina; Nelson Hamerschlak; Chitra M Hosing; Roy B Jones; Amado J Karduss Aurueta; Partow Kebriaei; John McMannis; Yago Nieto; Demetrios Petropoulos; Muzaffar H Qazilbash; Gabriela Rondon; Rima M Saliba; Manish Sharma; Elizabeth J Shpall; Laura L Worth; Marcos De Lima
Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant.
Leukemia & lymphoma 2012;53(5):901-6.
2012: Partow Kebriaei; Rajyalakshmi Luthra; Susan O'Brien; Uday Popat; Farhad Ravandi; Gabriela Rondon; Rima M Saliba; Elizabeth Shpall; Deborah Thomas; Laura L Worth; Alexandre Chiattone; Marcos De Lima; Sergio Giralt; Roy Jones; Hagop Kantarjian; Paolo Anderlini; Borje Andersson; Richard Champlin
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(4):584-92.
2011: Stefan O Ciurea; Marcos De Lima; Fleur Aung; Pedro Cano; Richard E Champlin; Ying Hu; Martin Korbling; Jeffrey J Molldrem; Gabriela Rondon; Elizabeth J Shpall; Peter F Thall; Sa A Wang; Xuemei Wang; Marcelo Fernandez-Vina
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.
Blood 2011;118(22):5957-64.
2011: Simrit Parmar; Marcos De Lima; H Joachim Deeg; Richard Champlin
Hematopoietic stem cell transplantation for myelodysplastic syndrome: a review.
Seminars in oncology 2011;38(5):693-704.
2011: Gheath Alatrash; Richard E Champlin; Alexandre Chiattone; Marcos De Lima; Leandro de Padua Silva; Sergio A Giralt; Nelson Hamerschlak; Chitra Hosing; Partow Kebriaei; Fabio Kerbauy; Yago Nieto; Matteo Pelosini; Muzaffar H Qazilbash; Gabriela Rondon; Rima M Saliba; Xuemei Wang; Lianchun Xiao; Weiqing Zhang; Borje S Andersson
Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(10):1490-6.
2011: Stefan O Ciurea; Marcos De Lima; Ying Jiang; John McMannis; Victor Mulanovich; Gabriela Rondon; Elizabeth J Shpall; Roland Bassett; Richard E Champlin
Lymphocyte recovery predicts outcomes in cord blood and T cell-depleted haploidentical stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(8):1169-75.
2011: Qaiser Bashir; Richard E Champlin; Alexandre Chiattone; Paolo Anderlini; Borje S Andersson; Leandro de Padua Silva; Marcelo Fernandez-Vina; Sergio Giralt; Uday Popat; Morgani Rodrigues; Manish Sharma; Elizabeth J Shpall; Wei Wei; Marcos De Lima
Unrelated donor transplantation for acute myelogenous leukemia in first remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(7):1067-71.
2011: Yiming Chen; Jorge Cortes; Marcos De Lima; Zeev Estrov; Stefan Faderl; Guillermo Garcia-Manero; Xuelin Huang; Tapan Kadia; Hagop Kantarjian; Partow Kebriaei; Sherry Pierce; Wei Qiao; Lynne Abruzzo; Farhad Ravandi
Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(18):2507-13.
2011: Richard Champlin; Paolo Anderlini; Borje Andersson; Elias Jabbour; Partow Kebriaei; Marcos De Lima
Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitors.
Clinical lymphoma, myeloma & leukemia 2011;11 Suppl 1():S96-100.
2011: Stefan O Ciurea; Rima M Saliba; Gabriela Rondon; Poliana A Patah; Fleur Aung; Pedro Cano; Borje S Andersson; Partow Kebriaei; Uday Popat; Marcelo Fernandez-Vina; Richard E Champlin; Marcos De Lima
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(6):923-9.
2011: Borje S Andersson; Benigno C Valdez; Marcos De Lima; Xuemei Wang; Peter F Thall; Laura L Worth; Uday Popat; Timothy Madden; Chitra Hosing; Amin Alousi; Gabriela Rondon; Partow Kebriaei; Elizabeth J Shpall; Roy B Jones; Richard E Champlin
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(6):893-900.
2011: Simrit Parmar; Marcelo Fernandez-Vina; Marcos De Lima
Novel transplant strategies for generating graft-versus-leukemia effect in acute myeloid leukemia.
Current opinion in hematology 2011;18(2):98-104.
2011: V E Mulanovich; S I Ahmed; T Öztürk; F A Khokhar; Dimitrios P Kontoyiannis; Marcos De Lima
Toxoplasmosis in allo-SCT patients: risk factors and outcomes at a transplantation center with a low incidence.
Bone marrow transplantation 2011;46(2):273-7.
2011: Ulas Darda Bayraktar; Marcos De Lima; Stefan Octavian Ciurea
Advances in haploidentical stem cell transplantation.
Revista brasileira de hematologia e hemoterapia 2011;33(3):237-41.
2010: Farhad Ravandi; Jorge Cortes; Stefan Faderl; Susan O'Brien; Guillermo Garcia-Manero; Srdan Verstovsek; Fabio P S Santos; Jianqin Shan; Mark Brandt; Marcos De Lima; Sherry Pierce; Hagop Kantarjian
Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy.
Blood 2010;116(26):5818-23; quiz 6153.
2010: Marcos De Lima; Sergio Giralt; Peter F Thall; Leandro de Padua Silva; Roy B Jones; Krishna Komanduri; Thomas M Braun; Hoang Q Nguyen; Richard Champlin; Guillermo Garcia-Manero
Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.
Cancer 2010;116(23):5420-31.
2010: Nikolai Velev; Jorge Cortes; Richard Champlin; Dan Jones; Gabriela Rondon; Sergio Giralt; Gautam Borthakur; Hagop M Kantarjian; Marcos De Lima
Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I.
Cancer 2010;116(15):3631-7.
2010: S S Tung; S Parmar; Simon N Robinson; Marcos De Lima; Elizabeth J Shpall
Ex vivo expansion of umbilical cord blood for transplantation.
Best practice & research. Clinical haematology 2010;23(2):245-57.
2010: Stefan O Ciurea; Marcos De Lima; Sergio Giralt; Rima M Saliba; Carlos Bueso-Ramos; Borje S Andersson; Chitra M Hosing; Srdan Verstovsek; Richard E Champlin; Uday Popat
Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(4):555-9.
2010: Chitra Hosing; Partow Kebriaei; Amin Alousi; Paolo Anderlini; Richard E Champlin; Marcos De Lima; Hui Gao; Sergio Giralt; Martin Körbling; Bang-Ning Lee; John McMannis; Mark F Munsell; Uday Popat; Muzaffar H Qazilbash; James M Reuben; Elizabeth J Shpall; Issa Khouri
A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas.
Journal of blood medicine 2010;1():49-55.
2010: Simrit Parmar; Marcos De Lima
Hematopoietic stem cell transplantation for myelodysplastic syndrome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1 Suppl):S37-44.
2009: Daniel Couriel; Rima Saliba; Marcos De Lima; Sergio Giralt; Borje Andersson; Issa Khouri; Chitra Hosing; Cindy Ippoliti; Elizabeth J Shpall; Richard Champlin; Amin Alousi
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1555-62.
2009: F P S Santos; Stefan Faderl; Guillermo Garcia-Manero; Charles Koller; Miloslav Beran; Susan O'Brien; Sherry Pierce; Emil J Freireich; Xuelin Huang; Gautam Borthakur; Carlos E Bueso-Ramos; Marcos De Lima; Michael Keating; Jorge Cortes; Andrew Lamb; Farhad Ravandi
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution.
Leukemia 2009;23(12):2275-80.
2009: Paul Armistead; Marcos De Lima; Sherry Pierce; Wei Qiao; Xuemei Wang; Peter F Thall; Sergio Giralt; Farhad Ravandi; Andrew Lamb; Richard Champlin; Elihu Estey
Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1431-8.
2009: S S Kelly; C B S Sola; Marcos De Lima; Elizabeth J Shpall
Ex vivo expansion of cord blood.
Bone marrow transplantation 2009;44(10):673-81.
2009: Stefan O Ciurea; Marcos De Lima; Pedro Cano; Martin Korbling; Sergio Giralt; Elizabeth J Shpall; Xuemei Wang; Peter F Thall; Richard E Champlin; Marcelo Fernandez-Vina
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.
Transplantation 2009;88(8):1019-24.
2009: Jonas A de Souza; Rima M Saliba; Poliana Patah; Gabriela Rondon; Rachel Ribeiro; Leandro de Padua Silva; Muzaffar H Qazilbash; Chitra Hosing; Uday Popat; Yvonne Efebera; Richard E Champlin; Marcos De Lima
Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1094-9.
2009: Marcos De Lima
Cord blood transplants.
Clinical advances in hematology & oncology : H&O 2009;7(8):508-11.
2009: Stefan O Ciurea; Morgani Rodrigues; Sergio Giralt; Marcos De Lima
Aging, acute myelogenous leukemia, and allogeneic transplantation: do they belong in the same sentence?
Clinical lymphoma & myeloma 2009;9(4):289-97.
2009: Borje S Andersson; Marcos De Lima; Peter F Thall; Timothy Madden; James A Russell; Richard E Champlin
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.
Current opinion in oncology 2009;21 Suppl 1():S11-5.
2009: Uday Popat; Rima M Saliba; Rupinderjit Thandi; Chitra Hosing; Muzaffar H Qazilbash; Paolo Anderlini; Elizabeth J Shpall; John McMannis; Martin Körbling; Amin Alousi; Borje Andersson; Yago Nieto; Partow Kebriaei; Issa Khouri; Marcos De Lima; Donna Weber; Sheeba Thomas; Michael Wang; Roy Jones; Richard Champlin; Sergio Giralt
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):718-23.
2009: Chitra Hosing; Rima M Saliba; Sheena Ahlawat; Martin Körbling; Partow Kebriaei; Amin Alousi; Marcos De Lima; Julia-Grace Okoroji; John McMannis; Muzaffar H Qazilbash; Paolo Anderlini; Sergio Giralt; Richard E Champlin; Issa Khouri; Uday Popat
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
American journal of hematology 2009;84(6):335-7.
2009: L De Padua Silva; Marcos De Lima; Andrew Lamb; Stefan Faderl; Partow Kebriaei; Sergio Giralt; Jan Davisson; Guillermo Garcia-Manero; Richard Champlin; Jean-Pierre J Issa; Farhad Ravandi
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome.
Bone marrow transplantation 2009;43(11):839-43.
2009: Elias Jabbour; Sergio Giralt; Andrew Lamb; Guillermo Garcia-Manero; Madan Jagasia; Partow Kebriaei; Leandro de Padua; Elizabeth J Shpall; Richard Champlin; Marcos De Lima
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.
Cancer 2009;115(9):1899-905.
2009: Rima M Saliba; Krishna Komanduri; Sergio Giralt; J de Souza; P Patah; Betul Oran; Daniel Couriel; Gabriela Rondon; Richard E Champlin; Marcos De Lima
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.
Bone marrow transplantation 2009;43(9):685-92.
2009: Carlos A Ramos; Rima M Saliba; Leandro de Pádua; ola khorshid; Elizabeth J Shpall; Sergio Giralt; Poliana A Patah; Chitra M Hosing; Uday R Popat; Gabriela Rondon; Issa F Khouri; Yago Nieto; Richard E Champlin; Marcos De Lima
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Haematologica 2009;94(2):249-57.
2009: Richard Champlin; Marcos De Lima; Partow Kebriaei; Gabriela Rondon; Tobi Fisher; Elias Jabbour; Jorge E Cortés; Andrew Lamb; Paolo Anderlini; Amin Alousi; Chitra Hosing; Elizabeth J Shpall; Uday Popat; Muzaffar H Qazilbash; Borje Andersson; Sergio Giralt
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.
Clinical lymphoma & myeloma 2009;9 Suppl 3():S261-5.
2008: Benigno C Valdez; David Murray; Latha Ramdas; Marcos De Lima; Roy Jones; Steven M Kornblau; Daniel Betancourt; Yang Li; Richard E Champlin; Borje S Andersson
Altered gene expression in busulfan-resistant human myeloid leukemia.
Leukemia research 2008;32(11):1684-97.
2008: Amin M Alousi; Rima M Saliba; Grace-Julia Okoroji; Homer A Macapinlac; Chitra Hosing; Martin Korbling; Barry Samuels; Uday Popat; Partow Kebriaei; Paolo Anderlini; Muzaffar H Qazilbash; Marcos De Lima; Sergio Giralt; Richard E Champlin; Issa F Khouri
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.
British journal of haematology 2008;142(5):786-92.
2008: Issa F Khouri; Peter McLaughlin; Rima M Saliba; Chitra Hosing; Martin Korbling; Ming S Lee; L Jeffrey Medeiros; Luis Fayad; Felipe Samaniego; Amin Alousi; Paolo Anderlini; Daniel Couriel; Marcos De Lima; Sergio Giralt; Sattva S Neelapu; Naoto T Ueno; Barry I Samuels; Fredrick Hagemeister; Larry W Kwak; Richard E Champlin
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
Blood 2008;111(12):5530-6.
2008: Borje S Andersson; Marcos De Lima; Peter F Thall; Xuemei Wang; Daniel Couriel; Martin Korbling; Soonja Roberson; Sergio Giralt; Betty Pierre; James A Russell; Elizabeth J Shpall; Roy B Jones; Richard E Champlin
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):672-84.
2008: Chitra Hosing; Rima M Saliba; Grace-Julia Okoroji; Uday Popat; Daniel Couriel; T Ali; L De Padua Silva; Partow Kebriaei; Amin Alousi; Marcos De Lima; Muzaffar H Qazilbash; Paolo Anderlini; Sergio Giralt; Richard E Champlin; Issa Khouri
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1166-71.
2008: Marcos De Lima; John McMannis; A Gee; Krishna Komanduri; Daniel Couriel; Borje S Andersson; Chitra Hosing; Issa Khouri; R Jones; Richard Champlin; Safa Karandish; T Sadeghi; T Peled; F Grynspan; Yaron Daniely; A Nagler; Elizabeth J Shpall
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
Bone marrow transplantation 2008;41(9):771-8.
2008: Paolo Anderlini; Rima M Saliba; Sandra Acholonu; Sergio Giralt; Borje Andersson; Naoto T Ueno; Chitra Hosing; Issa F Khouri; Daniel Couriel; Marcos De Lima; Muzaffar H Qazilbash; Barbara Pro; Jorge Romaguera; Luis Fayad; Fredrick Hagemeister; Anas Younes; Mark F Munsell; Richard E Champlin
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
Haematologica 2008;93(2):257-64.
2008: Marcos De Lima; Richard E Champlin; Peter F Thall; X Wang; Thomas G Martin; John D Cook; G McCormick; Muzaffar H Qazilbash; Partow Kebriaei; Daniel Couriel; Elizabeth J Shpall; Issa Khouri; Paolo Anderlini; Chitra Hosing; Ka Wah Chan; Borje S Andersson; P A Patah; Z Caldera; Elias Jabbour; Sergio Giralt
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
Leukemia 2008;22(2):258-64.
2007: Mohamed L Sorror; Sergio Giralt; Brenda M Sandmaier; Marcos De Lima; Munir Shahjahan; David G Maloney; H Joachim Deeg; Frederick R Appelbaum; Barry Storer; Rainer Storb
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.
Blood 2007;110(13):4606-13.
2007: Krishna Komanduri; Lisa S St John; Marcos De Lima; John McMannis; Steven Rosinski; Ian K McNiece; Susan G Bryan; Indreshpal Kaur; Sean Martin; Eric Wieder; Laura L Worth; Laurence J N Cooper; Demetrios Petropoulos; Jeffrey J Molldrem; Richard E Champlin; Elizabeth J Shpall
Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing.
Blood 2007;110(13):4543-51.
2007: Betul Oran; Sergio Giralt; Daniel Couriel; Chitra Hosing; Elizabeth J Shpall; Ernesto de Meis; Issa F Khouri; Muzaffar H Qazilbash; Paolo Anderlini; Partow Kebriaei; Uday Popat; Antonio Carrasco-Yalan; Richard E Champlin; Marcos De Lima
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
Leukemia 2007;21(12):2540-4.
2007: Partow Kebriaei; Michelle A Detry; Sergio Giralt; Antonio Carrasco-Yalan; Athanasios Anagnostopoulos; Daniel Couriel; Issa F Khouri; Paolo Anderlini; Chitra Hosing; Amin Alousi; Richard E Champlin; Marcos De Lima
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.
Blood 2007;110(9):3456-62.
2007: E Gurkan; P A Patah; Rima M Saliba; C A Ramos; B S Anderson; Richard Champlin; Marcos De Lima; Benjamin Lichtiger
Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2007;40(5):461-4.
2007: P A Patah; S Parmar; John McMannis; T Sadeghi; Safa Karandish; Gabriela Rondon; Jeffrey J Tarrand; Richard Champlin; Marcos De Lima; Elizabeth J Shpall
Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
Bone marrow transplantation 2007;40(4):365-8.
2007: Elias Jabbour; Jorge Cortes; Andrew Lamb; Sergio Giralt; Borje S Andersson; Francis Giles; Elizabeth J Shpall; Partow Kebriaei; Richard Champlin; Marcos De Lima
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity.
Cancer 2007;110(2):340-4.
2007: Amin Alousi; Marcos De Lima
Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Clinical advances in hematology & oncology : H&O 2007;5(7):560-70.
2007: Evren Ozdemir; Rima M Saliba; Richard E Champlin; Daniel Couriel; Sergio Giralt; Marcos De Lima; Issa F Khouri; Chitra Hosing; Steven M Kornblau; Paolo Anderlini; Elizabeth J Shpall; Muzaffar H Qazilbash; Jeffrey J Molldrem; Roy F Chemaly; Krishna Komanduri
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.
Bone marrow transplantation 2007;40(2):125-36.
2007: Betul Oran; Sergio Giralt; Rima M Saliba; Chitra Hosing; Uday Popat; Issa Khouri; Daniel Couriel; Muzaffar H Qazilbash; Paolo Anderlini; Partow Kebriaei; Shubhra Ghosh; Antonio Carrasco-Yalan; Ernesto de Meis; Athanasios Anagnostopoulos; Michele Donato; Richard E Champlin; Marcos De Lima
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):454-62.
2007: Rima M Saliba; Marcos De Lima; Sergio Giralt; Borje Andersson; Issa F Khouri; Chitra Hosing; Shubhra Ghosh; Joyce Neumann; Yvonne Hsu; Jorge De Jesus; Muzaffar H Qazilbash; Richard E Champlin; Daniel Couriel
Hyperacute GVHD: risk factors, outcomes, and clinical implications.
Blood 2007;109(7):2751-8.
2007: Muzaffar H Qazilbash; Rima M Saliba; Chitra Hosing; Floralyn Mendoza; S R Qureshi; Donna M Weber; Michael Wang; T Flosser; Daniel Couriel; Marcos De Lima; Partow Kebriaei; Uday Popat; Amin Alousi; Richard E Champlin; Sergio Giralt
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
Bone marrow transplantation 2007;39(5):279-83.
2007: Elihu Estey; Marcos De Lima; Raoul Tibes; Sherry Pierce; Andrew Lamb; Richard Champlin; Sergio Giralt
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).
Blood 2007;109(4):1395-400.
2007: Timothy Madden; Marcos De Lima; Neil Thapar; John Nguyen; Soonja Roberson; Daniel Couriel; Betty Pierre; Elizabeth J Shpall; Roy B Jones; Richard E Champlin; Borje S Andersson
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(1):56-64.
2006: L Lekakis; Sergio Giralt; Daniel Couriel; Elizabeth J Shpall; Chitra Hosing; Issa F Khouri; Paolo Anderlini; Martin Korbling; T Martin; Richard E Champlin; Marcos De Lima
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
Bone marrow transplantation 2006;38(6):421-6.
2006: Muzaffar H Qazilbash; Naoto T Ueno; Chitra Hosing; Marcos De Lima; J Cortes; A Massaro; Z Rivera; M Deavers; J A Adachi; Richard E Champlin
Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation.
Bone marrow transplantation 2006;38(5):393-4.
2006: Elias Jabbour; Jorge Cortes; Hagop M Kantarjian; Sergio Giralt; Dan Jones; Roy Jones; Francis Giles; Borje S Andersson; Richard Champlin; Marcos De Lima
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.
Blood 2006;108(4):1421-3.
2006: H J Lee; Betul Oran; Rima M Saliba; Daniel Couriel; K Shin; P Massey; J Neumann; Marcos De Lima; R Champlin; Sergio Giralt
Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy.
Bone marrow transplantation 2006;38(4):299-303.
2006: Partow Kebriaei; Rima M Saliba; C Ma; Cindy Ippoliti; Daniel Couriel; Marcos De Lima; Sergio Giralt; Muzaffar H Qazilbash; James L Gajewski; Chul Ha; Richard E Champlin; Issa F Khouri
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia.
Bone marrow transplantation 2006;38(3):203-9.
2006: Chitra Hosing; Rima M Saliba; Martin Körbling; Sandra Acholonu; John McMannis; Paolo Anderlini; Sergio Giralt; Marcos De Lima; Grace-Julia Okoroji; Daniel Couriel; Richard Champlin; Issa F Khouri; Michele L Donato
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2006;47(7):1290-4.
2006: Marcos De Lima; Elizabeth J Shpall
Strategies for widening the use of cord blood in hematopoietic stem cell transplantation.
Haematologica 2006;91(5):584-7.
2006: Daniel Couriel; Chitra Hosing; Rima M Saliba; Elizabeth J Shpall; Paolo Anderlini; Beverly Rhodes; Veronica Smith; Issa Khouri; Sergio Giralt; Marcos De Lima; Yvonne Hsu; Shubhra Ghosh; Joyce Neumann; Borje Andersson; Muzaffar H Qazilbash; Sharon R Hymes; Stella Kim; Richard Champlin; Michele Donato
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.
Blood 2006;107(8):3074-80.
2006: Marcos De Lima; Sergio Giralt
Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.
Seminars in hematology 2006;43(2):107-17.
2006: Muzaffar H Qazilbash; Rima M Saliba; Marcos De Lima; Chitra Hosing; Daniel Couriel; Ana Aleman; Linda Roden; Richard Champlin; Sergio Giralt
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma.
Cancer 2006;106(5):1084-9.
2006: Hong Yang; C Eaves; Marcos De Lima; M S Lee; Richard E Champlin; John McMannis; Simon N Robinson; T Niu; William Decker; Dongxia Xing; J Ng; Sufang Li; Xin Yao; Allen Eaves; R Jones; Borje S Andersson; Elizabeth J Shpall
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
Bone marrow transplantation 2006;37(6):575-82.
2006: Simon N Robinson; J Ng; T Niu; Hong Yang; John McMannis; Safa Karandish; Indreshpal Kaur; P Fu; M Del Angel; R Messinger; F Flagge; Marcos De Lima; William Decker; Dongxia Xing; Richard Champlin; Elizabeth J Shpall
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells.
Bone marrow transplantation 2006;37(4):359-66.
2006: S Parmar; Simon N Robinson; Krishna Komanduri; Lisa S St John; William Decker; Dongxia Xing; Hong Yang; John McMannis; Richard Champlin; Marcos De Lima; Jeffrey J Molldrem; A Rieber; Mark Bonyhadi; Ronald J Berenson; Elizabeth J Shpall
Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.
Cytotherapy 2006;8(2):149-57.
2006: Dongxia Xing; William Decker; Sufang Li; Simon N Robinson; Hong Yang; H Segal; S O'Connor; Xin Yao; Krishna Komanduri; John McMannis; R B Jones; Marcos De Lima; Richard E Champlin; Elizabeth J Shpall
AML-loaded DC generate Th1-type cellular immune responses in vitro.
Cytotherapy 2006;8(2):95-104.
2005: Aida Narvios; Marcos De Lima; H Shah; Benjamin Lichtiger
Transfusion of leukoreduced cellular blood components from cytomegalovirus-unscreened donors in allogeneic hematopoietic transplant recipients: analysis of 72 recipients.
Bone marrow transplantation 2005;36(6):499-501.
2005: J Alamo; Munir Shahjahan; Hillard M Lazarus; Marcos De Lima; Sergio Giralt
Comorbidity indices in hematopoietic stem cell transplantation: a new report card.
Bone marrow transplantation 2005;36(6):475-9.
2005: Chitra Hosing; Rima M Saliba; Munir Shahjahan; Elihu H Estey; Daniel Couriel; Sergio Giralt; Borje Andersson; Richard E Champlin; Marcos De Lima
Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia.
Bone marrow transplantation 2005;36(2):157-62.
2005: Andrew Lamb; Moshe Talpaz; Susan O'Brien; Francis Giles; Stefan Faderl; Srdan Verstovsek; Guillermo Garcia-Manero; Jianqin Shan; Mary Beth Rios; Richard Champlin; Marcos De Lima; Jorge Cortes
Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia--comparison with historic experience.
Cancer 2005;103(10):2099-108.
2005: Paolo Anderlini; Rima M Saliba; Sandra Acholonu; Grace-Julia Okoroji; Michele Donato; Sergio Giralt; Borje Andersson; Naoto T Ueno; Issa Khouri; Marcos De Lima; Chitra Hosing; Agueda Cohen; Cindy Ippoliti; Jorge Romaguera; M A Rodriguez; Barbara Pro; Luis Fayad; Andre Goy; Anas Younes; Richard E Champlin
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen.
Bone marrow transplantation 2005;35(10):943-51.
2005: Issa F Khouri; Rima M Saliba; Chitra Hosing; Grace-Julia Okoroji; Sandra Acholonu; Paolo Anderlini; Daniel Couriel; Marcos De Lima; Michele L Donato; Luis Fayad; Sergio Giralt; Roy Jones; Martin Korbling; Farzaneh Maadani; John T Manning; Barbara Pro; Elizabeth J Shpall; Anas Younes; Peter McLaughlin; Richard E Champlin
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2240-7.
2005: Raymond Wong; Munir Shahjahan; Xuemei Wang; Peter F Thall; Marcos De Lima; Issa Khouri; James L Gajewski; Jorge Alamo; Daniel Couriel; Borje S Andersson; Michele Donato; Chitra Hosing; Krishna Komanduri; Paolo Anderlini; Jeffrey J Molldrem; Naoto T Ueno; Elihu Estey; Cindy Ippoliti; Richard Champlin; Sergio Giralt
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):108-14.
2005: S Robinson; T Niu; Marcos De Lima; J Ng; Hong Yang; John McMannis; Safa Karandish; T Sadeghi; P Fu; M del Angel; S O'Connor; Richard Champlin; Elizabeth J Shpall
Ex vivo expansion of umbilical cord blood.
Cytotherapy 2005;7(3):243-50.
2004: Marcos De Lima; Athanasios Anagnostopoulos; Mark F Munsell; Munir Shahjahan; Naoto Ueno; Cindy Ippoliti; Borje S Andersson; James L Gajewski; Daniel Couriel; Jorge Cortes; Michele Donato; Joyce Neumann; Richard Champlin; Sergio Giralt
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation.
Blood 2004;104(3):865-72.
2004: Marcos De Lima; Daniel Couriel; Peter F Thall; Xuemei Wang; Timothy Madden; Roy Jones; Elizabeth J Shpall; Munir Shahjahan; Betty Pierre; Sergio Giralt; Martin Korbling; James A Russell; Richard E Champlin; Borje S Andersson
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.
Blood 2004;104(3):857-64.
2004: Daniel Couriel; Rima M Saliba; Krystal Hicks; Cindy Ippoliti; Marcos De Lima; Chitra Hosing; Issa Khouri; Borje Andersson; James L Gajewski; Michele Donato; Paolo Anderlini; Dimitrios P Kontoyiannis; Agueda Cohen; Thomas Martin; Sergio Giralt; Richard Champlin
Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.
Blood 2004;104(3):649-54.
2004: Marcos De Lima; Elizabeth J Shpall
Ex-vivo purging of hematopoietic progenitor cells.
Current hematology reports 2004;3(4):257-64.
2004: Maha El-Zimaity; Rima M Saliba; Kawah Chan; Munir Shahjahan; Antonio Carrasco; ola khorshid; Humberto Caldera; Daniel Couriel; Sergio Giralt; Issa Khouri; Cindy Ippoliti; Richard Champlin; Marcos De Lima
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters.
Blood 2004;103(12):4674-80.
2004: P Mittal; Rima M Saliba; Sergio Giralt; Munir Shahjahan; A I Cohen; Safa Karandish; Francesco Onida; Miloslav Beran; Richard E Champlin; Marcos De Lima
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Bone marrow transplantation 2004;33(10):1005-9.
2004: Michele L Donato; Ana Aleman; Richard E Champlin; Donna Weber; Raymond Alexanian; Cindy Ippoliti; Marcos De Lima; Athanasios Anagnostopoulos; Sergio Giralt
High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma.
Leukemia & lymphoma 2004;45(4):755-9.
2004: Daniel Couriel; Rima M Saliba; Sergio Giralt; Issa Khouri; Borje Andersson; Marcos De Lima; Chitra Hosing; Paolo Anderlini; Michele Donato; Karen Cleary; James L Gajewski; Joyce Neumann; Cindy Ippoliti; Gabriela Rondon; Agueda Cohen; Richard Champlin
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):178-85.
2003: ola khorshid; Ernesto de Meis; T Martin; R B Jones; Elizabeth J Shpall; Y Nieto; I Khouri; Munir Shahjahan; James L Gajewski; Sergio Giralt; Richard Champlin; Marcos De Lima
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant.
Leukemia 2003;17(12):2538-40.
2003: Borje S Andersson; Ashwin Kashyap; Daniel Couriel; Timothy Madden; Marcos De Lima; Peter F Thall; Hugo Fernandez; William Vaughan; Roy Jones; John R Wingard; Karl G Blume; Richard E Champlin
Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(11):722-4.
2003: David S Hong; Kalen L Jacobson; Issam I Raad; Marcos De Lima; Paolo Anderlini; Gregory N Fuller; Cindy Ippoliti; Rita M Cool; Norman E Leeds; Aida Narvios; Xiang Y Han; Anthony Padula; Richard E Champlin; Chitra Hosing
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(8):1044-9.
2003: Raymond Wong; Sergio Giralt; Thomas Martin; Daniel Couriel; Athanasios Anagnostopoulos; Chitra Hosing; Borje S Andersson; Pedro Cano; Munir Shahjahan; Cindy Ippoliti; Elihu H Estey; John McMannis; James L Gajewski; Richard E Champlin; Marcos De Lima
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.
Blood 2003;102(8):3052-9.
2003: Maha Ahmed; Francis Giles; Youngson Joe; Donna M Weber; Iman Jilani; Taghi Manshouri; Sergio Giralt; Marcos De Lima; Michael Keating; Maher Albitar
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma.
European journal of haematology 2003;71(3):174-8.
2003: Raymond Wong; Guillermo Z Beguelin; Marcos De Lima; Sergio Giralt; Chitra Hosing; Cindy Ippoliti; Arthur Forman; Ashok J Kumar; Richard Champlin; Daniel Couriel
Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation.
British journal of haematology 2003;122(1):128-34.
2003: Raymond Wong; Marcos De Lima; Daniel Couriel; Sergio Giralt; Chitra Hosing; Munir Shahjahan; Yee Chung Cheng; Jill Bruton; Richard Champlin; Issa Khouri
Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab.
Leukemia & lymphoma 2003;44(5):829-32.
2003: Marcos De Lima; Farhad Ravandi; Munir Shahjahan; Borje Andersson; Daniel Couriel; Michele Donato; Issa Khouri; James L Gajewski; Koen van Besien; Richard Champlin; Sergio Giralt; Andrew Lamb
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.
Cancer 2003;97(5):1242-7.
2003: Richard Champlin; Issa Khouri; Paolo Anderlini; Marcos De Lima; Chitra Hosing; John McMannis; Jeffrey J Molldrem; Naoto Ueno; Sergio Giralt
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.
Oncology (Williston Park, N.Y.) 2003;17(1):94-100; discussion 103-7.
2002: Marcos De Lima; Lisa S St John; Eric Wieder; Ming S Lee; John McMannis; Safa Karandish; Sergio Giralt; Miloslav Beran; Daniel Couriel; Martin Korbling; Samer Bibawi; Richard Champlin; Krishna Komanduri
Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units.
British journal of haematology 2002;119(3):773-6.
2002: Daniel Couriel; G Z Beguelin; Sergio Giralt; Marcos De Lima; Chitra Hosing; M A Kharfan-Dabaja; Athanasios Anagnostopoulos; Richard Champlin
Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
Bone marrow transplantation 2002;30(8):543-6.
2002: Hagop M Kantarjian; Susan O'Brien; Jorge E Cortes; Sergio Giralt; Mary Beth Rios; Jianqin Shan; Francis Giles; Deborah A Thomas; Stefan Faderl; Marcos De Lima; Guillermo Garcia-Manero; Richard Champlin; Ralph B Arlinghaus; Moshe Talpaz
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia.
Blood 2002;100(5):1590-5.
2002: Chitra Hosing; Mark F Munsell; Salim Yazji; Borje Andersson; Daniel Couriel; Marcos De Lima; Michele Donato; James L Gajewski; Sergio Giralt; Martin Körbling; T Martin; Naoto T Ueno; Richard E Champlin; Issa F Khouri
Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(3):450-9.
2002: Borje S Andersson; Peter F Thall; Timothy Madden; Daniel Couriel; Xuemei Wang; Hai T Tran; Paolo Anderlini; Marcos De Lima; James L Gajewski; Richard E Champlin
Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):477-85.
2001: J Rodriguez; Mark F Munsell; Salim Yazji; Fredrick B Hagemeister; Anas Younes; Borje Andersson; Sergio Giralt; James L Gajewski; Marcos De Lima; Daniel Couriel; Jorge Romaguera; Fernando Cabanillas; Richard E Champlin; Issa F Khouri
Impact of high-dose chemotherapy on peripheral T-cell lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(17):3766-70.
2000: Marcos De Lima; Koen van Besien; James L Gajewski; Issa Khouri; Borje Andersson; Martin Korbling; Richard Champlin; Sergio Giralt
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
Bone marrow transplantation 2000;26(3):333-8.
1998: Uday Popat; D Przepiork; Richard Champlin; WC Pugh; K Amin; RC Mehra; J Rodriguez; Sergio Giralt; Jorge Romaguera; A Rodriguez; Alejandro Preti; Borje Andersson; Issa Khouri; David F Claxton; Marcos De Lima; Michele Donato; Paolo Anderlini; James L Gajewski; Fernando Cabanillas; Koen van Besien
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):63-9.
1997: Marcos De Lima; S S Strom; Michael Keating; Andrew Lamb; Sherry Pierce; Susan O'Brien; Emil J Freireich; Elihu Estey
Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to work.
Blood 1997;90(12):4719-24.
1997: Koen van Besien; Marcos De Lima; Sergio Giralt; D F Moore; Issa F Khouri; Gabriela Rondón; RC Mehra; Borje S Andersson; C Dyer; Karen Cleary; Donna Przepiorka; James L Gajewski; Richard E Champlin
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
Bone marrow transplantation 1997;19(10):977-82.
1997: Marcos De Lima; Koen van Besien; Sergio Giralt; Issa F Khouri; RC Mehra; Borje S Andersson; Donna Przepiorka; James L Gajewski; Martin Korbling; Richard E Champlin
Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
Bone marrow transplantation 1997;19(2):121-7.